Kalvista Pharmaceuticals Inc (KALV) Insider Trading

Total insider buys:
  • $45,015,517.47
Total insider sells:
  • $68,838,447.81
Most recent insider trade:
  • Feb. 20, 2024
Most active insider trader:
  • Thomas Andrew Crockett
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 20, 2024CFO22,802$14.11Sell$321,736.22
Feb. 20, 2024CEO24,888$14.11Sell$351,169.68
Feb. 20, 2024Insider28,288$14.07Sell$398,012.16
Feb. 8, 2024Major Shareholder29,747$14.70Buy$437,280.90
Feb. 6, 2024Major Shareholder4,474$14.74Buy$65,946.76
Jan. 29, 2024Major Shareholder80,600$14.22Buy$1,146,132.00
Jan. 26, 2024Major Shareholder4,174$12.98Buy$54,178.52
Jan. 24, 2024Major Shareholder20,686$12.44Buy$257,333.84
Jan. 22, 2024Major Shareholder67,546$12.55Buy$847,702.30
Jan. 18, 2024Major Shareholder39,680$12.51Buy$496,396.80
Jan. 16, 2024Major Shareholder19,599$12.73Buy$249,495.27
Jan. 11, 2024Insider22,679$13.03Sell$295,507.37
Jan. 10, 2024Major Shareholder47,700$12.67Buy$604,359.00
Jan. 8, 2024Insider17,221$13.01Sell$224,045.21
Jan. 8, 2024Major Shareholder69,184$12.44Buy$860,648.96
Jan. 3, 2024Major Shareholder17,605$12.20Buy$214,781.00
Dec. 29, 2023Major Shareholder6,013$12.49Buy$75,102.37
Dec. 27, 2023Major Shareholder41,514$11.97Buy$496,922.58
Dec. 27, 2023CEO30,000$12.02Sell$360,600.00
Sept. 11, 2023Director18,000$10.50Sell$189,000.00
Aug. 18, 2023CFO13,067$10.73Sell$140,208.91
Aug. 18, 2023Insider8,020$10.73Sell$86,054.60
Aug. 18, 2023CEO14,876$10.73Sell$159,619.48
May 18, 2023CFO4,037$10.14Sell$40,935.18
May 18, 2023Insider2,604$10.14Sell$26,404.56
May 18, 2023CEO5,627$10.14Sell$57,057.78
Feb. 17, 2023Insider3,412$7.66Sell$26,135.92
Feb. 17, 2023CFO4,954$7.66Sell$37,947.64
Feb. 17, 2023CEO6,700$7.66Sell$51,322.00
Nov. 18, 2022CEO1,785$5.44Sell$9,710.40
Nov. 18, 2022CFO722$5.44Sell$3,927.68
Nov. 18, 2022Insider1,139$5.44Sell$6,196.16
Aug. 17, 2022CEO1,797$14.96Sell$26,883.12
March 9, 2022CEO10,000$17.07Sell$170,700.00
Nov. 1, 2021Insider6,000$18.07Sell$108,420.00
Oct. 1, 2021CEO10,000$17.18Sell$171,800.00
Aug. 2, 2021Insider5,000$20.52Sell$102,600.00
July 1, 2021CEO10,000$24.15Sell$241,500.00
June 17, 2021CEO1,067$30.04Sell$32,052.68
June 9, 2021CEO8,933$30.05Sell$268,436.65
May 3, 2021Insider5,000$24.84Sell$124,200.00
April 29, 2021SVP88,030$25.28Sell$2,225,398.40
April 28, 2021VP10,014$25.76Sell$257,960.64
April 27, 2021SVP11,017$25.79Sell$284,128.43
April 1, 2021CEO10,000$27.44Sell$274,400.00
Feb. 23, 2021CFO29,642$33.59Sell$995,674.78
Feb. 23, 2021Insider15,000$33.59Sell$503,850.00
Feb. 23, 2021CEO10,000$33.55Sell$335,500.00
Oct. 30, 2020Director115,686$17.24Buy$1,994,426.64
Oct. 29, 2020Insider5,000$17.48Sell$87,400.00
First«1 of 2»Last
  • Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.

  • The insider traders at Kalvista Pharmaceuticals Inc are: Thomas Andrew Crockett, Venrock Healthcare Capital Par, Christopher Yea, Albert Cha, Benjamin L Palleiko, Edward P Feener, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Andreas Maetzel, Paul K Audhya, Acmp Iv Llc, David Renzi, Daniel B Soland, Rajeev M Shah, and Michael David Smith

  • The most active insider trader at Kalvista Pharmaceuticals Inc is Thomas Andrew Crockett with 22 trades.

  • Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.

  • Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.

  • The most recent insider trade for Kalvista Pharmaceuticals Inc was on Feb. 20, 2024.

  • The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.

  • The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.